Skip to main content
Clinical Trials/NCT06629701
NCT06629701
Enrolling By Invitation
Not Applicable

A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization

University Hospital Pilsen2 sites in 1 country150 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
External support for vein grafts
Conditions
Heart Attack, Revascularization
Sponsor
University Hospital Pilsen
Enrollment
150
Locations
2
Primary Endpoint
Closing of bypass in time
Status
Enrolling By Invitation
Last Updated
23 days ago

Overview

Brief Summary

The aim of the thesis is to compare a group of patients using vein grafts with and without external support, specifically their patency. This is a prospective study with a follow-up plan of 150 patients, in whom the functionality of the grafts will be monitored at time intervals.

Detailed Description

One of the most frequently used strategies to restore blood flow in affected coronary arteries in atherosclerotic disease is coronary bypass, or bridging of a narrowed or closed artery and revascularization of the ischemic area of the heart. For coronary artery bypass grafting (CABG), the great saphenous vein (VSM) remains the most commonly used graft, although the longevity of the vein graft is an important limiting factor in monitoring long-term results of CABG. Long-term follow-up found that 25% of vein grafts close within 1 year of surgery, and up to 75% of vein grafts close 10 years after surgery. External support minimizes pathophysiological processes in the graft. For example, intimal hyperplasia, kinking, graft dilatation or graft suppression and generally improving the hemodynamic flow through the graft should also reduce the formation of thrombus. In this study we follow up the patency and function of vein grafts over a period of 4 years, and compare the resulting data with already available data from other researches.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 31, 2027
Last Updated
23 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital Pilsen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • elective cardiosurgical revascularization using VSM vein graft, i.e. patients with MVD findings.

Exclusion Criteria

  • thromboembolic event in the past, long-term warfarinization, mechanical valves, infection during the procedure, urgent procedure, allergy to contrast material, pregnancy, elevated creatinine. A relative contraindication for exclusion from the study is: VSM varicosity, VSM damage during sampling.The age, gender or weight of the patient has no influence on the indication.

Arms & Interventions

Group A

Group A will consist of a group of patients who will be sutured with external support for vein grafts.

Intervention: External support for vein grafts

Group B

Group B will be without sewn-in external supports.

Outcomes

Primary Outcomes

Closing of bypass in time

Time Frame: 3 years after the operation

Primary measures will be closing of the bypass in time, if there will be any.

Secondary Outcomes

  • Chest pain(3 years after the operation)
  • Shortness of breath at rest(3 years after the operation)

Study Sites (2)

Loading locations...

Similar Trials